Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Hill Dermaceuticals, Inc.
FDA Inspection
•Hill Dermaceuticals, Inc.•September 10, 2010

Hill Dermaceuticals, Inc. – FDA Inspection, Sep 10, 2010

Record Details

This FDA Inspection record concerns Hill Dermaceuticals, Inc., with an inspection on September 10, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Hill Dermaceuticals, Inc.
Inspection Date
September 10, 2010
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · b81ebccb-bec5-4e2d-8d75-c41d109bc826

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
680869
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

16
  1. 21 CFR 211.188Prepared for each batch, include complete information
  2. 21 CFR 211.28(a)Clothing appropriate for duties performed
  3. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  4. 21 CFR 211.160(a)Deviations from laboratory control requirements
  5. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  6. 21 CFR 211.160(a)Following/documenting laboratory controls
  7. 21 CFR 211.160(b)(2)In-process sample representation/identification
  8. 21 CFR 211.194(a)Complete test data included in records
  9. 21 CFR 211.194(d)Laboratory equipment calibration records
  10. 21 CFR 211.198(a)Complaint Handling Procedure

Showing 10 of 16 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Hill Dermaceuticals, Inc.

7
DateClassificationOfficeProject area
October 14, 2025VAIFlorida District OfficeDrug Quality Assurance
August 11, 2021VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 18, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
October 6, 2014VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 10, 2012OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for Hill Dermaceuticals, Inc.
  • FDA Inspection 1287088 - 2025-10-14
  • FDA Inspection 1149082 - 2021-08-11
  • FDA Inspection 1053606 - 2018-05-18
  • FDA Inspection 899290 - 2014-10-06
  • FDA Inspection 794615 - 2012-08-10

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hill Dermaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.